Air India Pilot Undergoes Confirmatory Drug Test Following Severe In-Flight Altitude Drop
New Delhi, Sunday, 9 August 2026.
An Air India captain involved in an August 4, 2026, severe turbulence incident that dropped the plane 91 meters and injured 17 people requires secondary testing after an initial failed drug screening.
Confirmatory Testing Following Altitude Loss Incident
An Air India captain underwent secondary confirmatory drug testing following a failed initial screening triggered by a severe flight altitude drop [1]. The incident occurred on August 4, 2026, and raises fresh operational safety and regulatory oversight concerns for Tata Group as it continues its multi-billion-dollar restructuring and modernization effort for the flag carrier [1]. Aviation authorities are assessing the potential human factor compliance failures, which could prompt stricter workplace substance protocols across South Asian commercial airlines [1]. The India’s aviation ministry confirmed on Sunday, August 9, 2026, that the pilot whose flight plunged dramatically in turbulence is undergoing a confirmatory psychoactive drug test [1]. Samples have been sent to the designated laboratory for confirmatory analysis, and the final report is awaited [1].
Flight Details and Casualty Report
The Airbus A320, carrying 137 passengers and eight crew, lost around 300 feet (91 metres) on August 4 while flying from Phuket in Thailand to New Delhi, before stabilising and landing safely [1]. Eight passengers and four cabin crew members were admitted to hospitals after landing in the Indian capital, whose conditions were described as stable [1]. Subsequent reports indicate 13 passengers and four crew members were injured, with two crew members sustaining spinal injuries near the tailbone and neck [2]. The injury rate among those on board stands at approximately 11.724 percent based on available figures [1][3]. The Civil Aviation Minister stated the turbulence event lasted approximately 5 minutes and categorized the event as a serious incident [2].
Regulatory Investigation and Protocols
The ministry said the flight has been classified as a Serious Incident, and that India’s Aircraft Accident Investigation Bureau (AAIB) has launched an investigation [1]. The Directorate General of Civil Aviation has initiated an inquiry into the incident, and the aircraft has been moved for inspection [2]. Both pilots have been removed from the flying roster pending outcomes of the investigation [1]. Civil aviation regulations mandate that a first-time positive drug test requires referral to rehabilitation and a negative test report for return to service, while a second offense results in a 3-year license suspension, and a third offense results in license cancellation [2]. Air India stated it could not comment on the dope test findings since the results have not been shared with them yet [2].
Operational Implications for Air India
The screening test in respect of the Pilot-in-Command indicated a result requiring confirmatory testing [1]. Air India said the pilots underwent screening as per protocol but clarified that the test results have not been shared with the airline [3]. The Directorate General of Civil Aviation is investigating the incident, including the crew’s handling of the turbulence and whether the aircraft should have been diverted [3]. This development comes as the Indian carrier appointed a new executive on Wednesday, highlighting ongoing leadership changes during the restructuring phase [1]. The final report from the designated laboratory will determine the next steps regarding the pilot’s licensure and employment status [1].